Fosun International LTD Aeglea Bio Therapeutics, Inc. Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$6.42 - $9.0 $1.31 Million - $1.84 Million	-204,148 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$6.1 - $8.78 $170,800 - $245,839	28,000 Added 15.9%	204,148 $1.31 Million
Q1 2019 May 10, 2019	BUY	$7.6 - $9.4 $600,400 - $742,600	79,000 Added 81.32%	176,148 $1.4 Million
Q4 2018 Jan 31, 2019	BUY	$6.51 - $10.19 $632,433 - $989,938	97,148 New	97,148 $778,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.